• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锝-99m标记的pH(低)插入肽变体7的合成与评估,用于通过靶向肿瘤微环境早期诊断MDA-MB-231三阴性乳腺癌

Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.

作者信息

Chen Yuehua, Su Yuan, Pang Xufeng, Song Xiaoxia, Zhao Wanjun, Yu Mingming

机构信息

Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

Front Oncol. 2022 Apr 21;12:869260. doi: 10.3389/fonc.2022.869260. eCollection 2022.

DOI:10.3389/fonc.2022.869260
PMID:35530359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9069674/
Abstract

OBJECTIVE

To prepare technetium-99m (Tc)-labeled pH (low) insertion peptide variant 7 [pHLIP (Var7)] and carry out small-animal single-photon-emission computed tomography (SPECT)/computed tomography (CT) imaging of tumor-bearing nude mice to study its value in the early diagnosis of triple-negative breast cancer (TNBC).

METHODS

The pHLIP (Var7) sequence was synthesized solid-phase peptide synthesis. Four amino acids, Gly-(D)-Ala-Gly-Gly, were attached to the N-terminus of pHLIP (Var7) to form a strong chelating group containing an N4 structure. The peptide was labeled with Tc using a direct labeling method. We determined the binding fraction of Tc-pHLIP (Var7) to MDA-MB-231 cells. Serial biodistribution studies and small-animal SPECT/CT imaging in MDA-MB-231 TNBC-bearing mice were performed using Tc-pHLIP (Var7).

RESULTS

The radiochemical yield and purity of Tc-pHLIP (Var7) were 99.49 ± 0.17% and 99.63 ± 0.44%, respectively. The radiochemical purity was still more than 96% after 24 h in serum. The binding fraction of Tc-pHLIP (Var7) to MDA-MB-231 cells continuously increased in an acidic environment and was significantly higher than the cell-binding fraction (P < 0.01) at pH = 7.4 and the cell-binding fraction (P < 0.01) of Tc-kVar7 at different pH values (pH = 6.0, 6.5, 7.0 and 7.4) at each time point (P < 0.01). The distribution of Tc-pHLIP (Var7) in tumors at each time point was significantly greater than that of Tc-kVar7 (P < 0.01). SPECT/CT imaging was largely consistent with the biodistribution results; the tumor was clearly imaged at each time point after injection of Tc-pHLIP (Var7) but could not be imaged after injection of Tc-kVar7.

CONCLUSION

Tc-pHLIP (Var7) showed a high radiochemical yield and stability and was highly concentrated in tumor tissues. Although there was strong radioactive background in the abdomen of tumor-bearing nude mice, it did not hinder early diagnosis of TNBC.

摘要

目的

制备99m锝(Tc)标记的pH(低)插入肽变体7 [pHLIP(Var7)],并对荷瘤裸鼠进行小动物单光子发射计算机断层扫描(SPECT)/计算机断层扫描(CT)成像,以研究其在三阴性乳腺癌(TNBC)早期诊断中的价值。

方法

采用固相肽合成法合成pHLIP(Var7)序列。在pHLIP(Var7)的N端连接4个氨基酸Gly-(D)-Ala-Gly-Gly,形成含N4结构的强螯合基团。采用直接标记法用Tc标记该肽。测定了Tc-pHLIP(Var7)与MDA-MB-231细胞的结合率。使用Tc-pHLIP(Var7)对荷MDA-MB-231 TNBC的小鼠进行系列生物分布研究和小动物SPECT/CT成像。

结果

Tc-pHLIP(Var7)的放射化学产率和纯度分别为99.49±0.17%和99.63±0.44%。在血清中放置24 h后,放射化学纯度仍高于96%。在酸性环境中,Tc-pHLIP(Var7)与MDA-MB-231细胞的结合率持续升高,且在pH = 7.4时显著高于细胞结合率(P < 0.01),在每个时间点,其与不同pH值(pH = 6.0、6.5、7.0和7.4)下Tc-kVar7的细胞结合率相比也显著升高(P < 0.01)。各时间点Tc-pHLIP(Var7)在肿瘤中的分布均显著高于Tc-kVar7(P < 0.01)。SPECT/CT成像结果与生物分布结果基本一致;注射Tc-pHLIP(Var7)后各时间点肿瘤均清晰显影,而注射Tc-kVar7后肿瘤未显影。

结论

Tc-pHLIP(Var7)具有较高的放射化学产率和稳定性,且在肿瘤组织中高度浓聚。虽然荷瘤裸鼠腹部有较强的放射性本底,但不影响TNBC的早期诊断。

相似文献

1
Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.锝-99m标记的pH(低)插入肽变体7的合成与评估,用于通过靶向肿瘤微环境早期诊断MDA-MB-231三阴性乳腺癌
Front Oncol. 2022 Apr 21;12:869260. doi: 10.3389/fonc.2022.869260. eCollection 2022.
2
Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.放射性碘标记的pH(低)插入肽变体7样肽作为小鼠MDA-MB-231三阴性乳腺癌模型中非侵入性肿瘤微环境成像剂的合成与评价
Mol Imaging Biol. 2022 Aug;24(4):570-579. doi: 10.1007/s11307-021-01702-0. Epub 2022 Jan 10.
3
Inhibition of MDA-MB-231 cell proliferation by pHLIP(Var7)-P1AP and SPECT imaging of MDA-MB-231 breast cancer-bearing nude mice using 125I-pHLIP(Var7)-P1AP.pHLIP(Var7)-P1AP 抑制 MDA-MB-231 细胞增殖和 125I-pHLIP(Var7)-P1AP 用于荷 MDA-MB-231 乳腺癌裸鼠的 SPECT 成像。
Nuklearmedizin. 2021 Jun;60(3):240-248. doi: 10.1055/a-1307-1923. Epub 2021 Mar 23.
4
An Experimental Study on [I]I-pHLIP (Var7) for SPECT/CT Imaging of an MDA-MB-231 Triple-Negative Breast Cancer Mouse Model by Targeting the Tumor Microenvironment.靶向肿瘤微环境的 [I]I-pHLIP (Var7) 用于 SPECT/CT 成像 MDA-MB-231 三阴性乳腺癌小鼠模型的实验研究
Mol Imaging. 2021 Feb 16;2021:5565932. doi: 10.1155/2021/5565932. eCollection 2021.
5
pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.pHLIP(Var7)-P1AP 通过靶向蛋白酶激活受体 1 抑制 MDA-MB-231 三阴性乳腺癌细胞的增殖。
Breast Cancer Res Treat. 2020 Apr;180(2):379-384. doi: 10.1007/s10549-020-05560-2. Epub 2020 Feb 7.
6
Small animal PET imaging with the Ga-labeled pH (low) insertion peptide-like peptide YJL-4 in a triple-negative breast cancer mouse model.在三阴性乳腺癌小鼠模型中使用镓标记的pH(低)插入肽样肽YJL-4进行小动物PET成像。
EJNMMI Radiopharm Chem. 2024 Apr 27;9(1):33. doi: 10.1186/s41181-024-00267-x.
7
MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with Tc(I) Tricarbonyl Complex.使用六组氨酸肽修饰的帕尼单抗 Fab 进行 MicroSPECT/CT 成像,以实现 Tc(I)三羰基配合物标记,用于检测小鼠中细胞系和患者来源的 EGFR 阳性肿瘤异种移植物。
Mol Pharm. 2019 Aug 5;16(8):3559-3568. doi: 10.1021/acs.molpharmaceut.9b00422. Epub 2019 Jul 11.
8
Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.(99m)Tc-表皮生长因子受体(EGFR)-肽核酸的制备及评价用于恶性肿瘤中 EGFR 信使 RNA 表达的可视化。
J Nucl Med. 2014 Jun;55(6):1008-16. doi: 10.2967/jnumed.113.136101. Epub 2014 Apr 17.
9
99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.99mTc标记的雌二醇作为雌激素受体探针:制备与临床前评估。
Nucl Med Biol. 2016 Jan;43(1):89-96. doi: 10.1016/j.nucmedbio.2015.09.006. Epub 2015 Sep 21.
10
Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [Tc]-(I)-Tricarbonyl Complex.采用 [Tc]-(I)-三羰基复合物标记的帕妥珠单抗 Fab-六组氨酸肽免疫偶联物对 NOD/SCID 小鼠中 HER2 阳性肿瘤的成像
Mol Imaging Biol. 2021 Aug;23(4):495-504. doi: 10.1007/s11307-020-01571-z. Epub 2021 Jan 21.

引用本文的文献

1
Nanoparticle-Mediated CXCL12-CXCR4 Inhibition Reprograms Macrophages and Suppresses Gastric Carcinoma.纳米颗粒介导的CXCL12-CXCR4抑制作用可重编程巨噬细胞并抑制胃癌。
Adv Sci (Weinh). 2025 Aug;12(30):e00225. doi: 10.1002/advs.202500225. Epub 2025 Jun 19.
2
Targeted nanoparticle delivery system for tumor-associated macrophage reprogramming to enhance TNBC therapy.用于肿瘤相关巨噬细胞重编程以增强三阴性乳腺癌治疗的靶向纳米颗粒递送系统。
Cell Biol Toxicol. 2025 Mar 8;41(1):58. doi: 10.1007/s10565-025-10001-1.
3
Small animal PET imaging with the Ga-labeled pH (low) insertion peptide-like peptide YJL-4 in a triple-negative breast cancer mouse model.

本文引用的文献

1
Inhibition of MDA-MB-231 cell proliferation by pHLIP(Var7)-P1AP and SPECT imaging of MDA-MB-231 breast cancer-bearing nude mice using 125I-pHLIP(Var7)-P1AP.pHLIP(Var7)-P1AP 抑制 MDA-MB-231 细胞增殖和 125I-pHLIP(Var7)-P1AP 用于荷 MDA-MB-231 乳腺癌裸鼠的 SPECT 成像。
Nuklearmedizin. 2021 Jun;60(3):240-248. doi: 10.1055/a-1307-1923. Epub 2021 Mar 23.
2
An Experimental Study on [I]I-pHLIP (Var7) for SPECT/CT Imaging of an MDA-MB-231 Triple-Negative Breast Cancer Mouse Model by Targeting the Tumor Microenvironment.靶向肿瘤微环境的 [I]I-pHLIP (Var7) 用于 SPECT/CT 成像 MDA-MB-231 三阴性乳腺癌小鼠模型的实验研究
Mol Imaging. 2021 Feb 16;2021:5565932. doi: 10.1155/2021/5565932. eCollection 2021.
3
在三阴性乳腺癌小鼠模型中使用镓标记的pH(低)插入肽样肽YJL-4进行小动物PET成像。
EJNMMI Radiopharm Chem. 2024 Apr 27;9(1):33. doi: 10.1186/s41181-024-00267-x.
4
Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides.瞄准神奇子弹:通过pHLIP肽将成像和治疗剂靶向递送至实体瘤
Front Pharmacol. 2024 Mar 13;15:1355893. doi: 10.3389/fphar.2024.1355893. eCollection 2024.
5
Multiplexed Imaging Reveals the Spatial Relationship of the Extracellular Acidity-Targeting pHLIP with Necrosis, Hypoxia, and the Integrin-Targeting cRGD Peptide.多重成像揭示了细胞外酸度靶向 pHLIP 与坏死、缺氧以及整合素靶向 cRGD 肽的空间关系。
Cells. 2022 Nov 4;11(21):3499. doi: 10.3390/cells11213499.
pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.pHLIP(Var7)-P1AP 通过靶向蛋白酶激活受体 1 抑制 MDA-MB-231 三阴性乳腺癌细胞的增殖。
Breast Cancer Res Treat. 2020 Apr;180(2):379-384. doi: 10.1007/s10549-020-05560-2. Epub 2020 Feb 7.
4
Triple negative breast cancer: the kiss of death.三阴性乳腺癌:死亡之吻。
Oncotarget. 2017 Jul 11;8(28):46652-46662. doi: 10.18632/oncotarget.16938.
5
PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study.用(64)铜和(18)氟标记的pHLIP肽对肿瘤细胞外pH进行PET成像:一项构效关系优化研究。
Bioconjug Chem. 2016 Sep 21;27(9):2014-23. doi: 10.1021/acs.bioconjchem.6b00306. Epub 2016 Jul 21.
6
Synthesis and evaluation of Tc-99m-labeled RRL-containing peptide as a non-invasive tumor imaging agent in a mouse fibrosarcoma model.锝-99m标记的含RRL肽作为小鼠纤维肉瘤模型中非侵入性肿瘤成像剂的合成与评价
Ann Nucl Med. 2015 Nov;29(9):779-85. doi: 10.1007/s12149-015-1002-6. Epub 2015 Jul 16.
7
Targeting breast tumors with pH (low) insertion peptides.用pH(低)插入肽靶向乳腺肿瘤。
Mol Pharm. 2014 Aug 4;11(8):2896-905. doi: 10.1021/mp5002526. Epub 2014 Jul 8.
8
Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.(99m)Tc-表皮生长因子受体(EGFR)-肽核酸的制备及评价用于恶性肿瘤中 EGFR 信使 RNA 表达的可视化。
J Nucl Med. 2014 Jun;55(6):1008-16. doi: 10.2967/jnumed.113.136101. Epub 2014 Apr 17.
9
pH (low) insertion peptide (pHLIP) targets ischemic myocardium.pH(低)插入肽(pHLIP)靶向缺血性心肌。
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):82-6. doi: 10.1073/pnas.1220038110. Epub 2012 Dec 17.
10
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.原发性乳腺癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2011 Sep;22 Suppl 6:vi12-24. doi: 10.1093/annonc/mdr371.